companiesCompany
Biofrontera
Biofrontera is a German dermatology company whose photodynamic therapy product Ameluz (aminolevulinic acid gel) with its RhodoLED lamp treats actinic keratosis and, in Europe, superficial basal cell carcinoma.
Overview
Biofrontera AG developed Ameluz, a nanoemulsion gel of aminolevulinic acid approved in the EU in 2011 and the US in 2016 for actinic keratosis with red-light photodynamic therapy; the EU label also covers basal cell carcinoma. Biofrontera Inc. (Woburn, MA) commercialises it in the US.
Headquarters
Leverkusen, DE
Scorecard
All companies#79of 680 companies, score 33
- approved products +6
- modalities +2
- regions +2
- registry trials +23
1 approved, 0 in phase 3, 0 earlier, 0 targets, 135 registry studies. Formula on the scorecards page.
Type
pharma
Website